Observational studyNutrients2017

Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.

Enzo Vicari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.